Table 2.
Characteristics | Non-pulmonary complications (n = 181) | Pulmonary complication (n = 16) | p-value |
---|---|---|---|
Age ; years | 61 [47–70] | 66 [61–72] | 0.03 |
ASA-PS score | 2 [2–3] | 2 [2–3] | 0.26 |
Medical background; % | |||
Arterial hypertension | 70 (39%) | 11 (69%) | 0.02 |
Myocardial infarction | 11 (6%) | 1 (6%) | 1.00 |
Cardiac dysfunction | 1 (0.6%) | 1(6%) | 0.05 |
OSAS | 12 (7%) | 2 (13%) | 0.38 |
Smoking | 31 (17%) | 0 (0%) | 0.07 |
Arteritis | 2 (1%) | 2 (13%) | < 0.01 |
Stroke | 9 (5%) | 2 (13%) | 0.19 |
Diabetes | 31 (17%) | 4 (25%) | 0.42 |
Dyslipidemia | 35 (19%) | 4 (25%) | 0.26 |
Chronic renal disease | 10 (6%) | 1 (6%) | 1.00 |
Sugery; % | |||
Digestive | 157 (87%) | 15 (94%) | 0.42 |
Urological | 14 (8%) | 1 (6%) | 0.78 |
Gynecological | 10 (5%) | 0 (0%) | 0.36 |
Final cardiac index; l min−1 m−2 | 3.1 [2.5–3.7] | 3.4 [2.4–3.8] | 0.69 |
Final delta-B-line | 4 [2–7] | 7 [5–12] | < 0.01 |
Norepinephrine use; % | 60 (33%) | 9 (56%) | 0.07 |
Norepinephrine dose; µg kg−1 | 0.00 [0.00–0.04] | 0.05 [0.00–0.08] | 0.11 |
Total fluid administered; ml kg−1 | 9.4 [5.7–16.7] | 8.4 [6.7–13.2] | 0.67 |
Total blood loss; ml kg−1 | 4.9 [2.5–7.4] | 6.4 [4.5–8.7] | 0.66 |
Intraoperative duration; min | 120 [60–210] | 200 [130–240] | 0.01 |
Post-operative PaO2/FiO2; mmHg | 343 [273–419] | 290 [173–402] | 0.09 |
Postoperative BNP; ng ml−1 | 34 [16–92] | 37 [13–120] | 1.00 |
Length of stay; days | 4 [2–8] | 18 [13–36] | < 0.01 |
Significant values are in bold.
Values are means ± SD, numbers (proportion) or median [IQR].
Digestive surgery duodenopancreatectomy, hepatectomy, colectomy, gastrectomy, oesophagectomy, intraperitoneal hyperthermic chemotherapy. Urological surgery: cystectomy, nephrectomy, Gynecological surgery hysterectomy and ovariectomy, OSAS obstructive sleep apnea syndrome, ASA-PS American Society of Anesthesiology-Physical status, PaO2/FiO2 arterial oxygen partial pressure to fractional inspired oxygen ratio.